UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection

PLoS pathogens, 2014-11, Vol.10 (10), p.e1004497-e1004497

2014

Volltextzugriff (PDF)

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

The Lancet (British edition), 2009-09, Vol.374 (9692), p.796-806

2009

Volltextzugriff (PDF)

Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults

PLoS genetics, 2021-04, Vol.17 (4), p.e1009464

2021

Volltextzugriff (PDF)

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596

2013

Volltextzugriff (PDF)

Methylprednisolone for Coronavirus Disease 2019 (COVID-19): Was Benjamin Rush Prescient?

Clinical infectious diseases, 2021-05, Vol.72 (9), p.e382-e383

Lennox, Jeffrey L

2021

Volltextzugriff (PDF)

Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

Clinical infectious diseases, 2005-06, Vol.40 (11), p.1559-1585

2005

Volltextzugriff (PDF)

Impaired Hepatitis C Virus (HCV)-Specific Effector CD8+ T Cells Undergo Massive Apoptosis in the Peripheral Blood during Acute HCV Infection and in the Liver during the Chronic Phase of Infection

Journal of Virology, 2008-10, Vol.82 (20), p.9808-9822

2008

Volltextzugriff (PDF)

A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study

AIDS research and human retroviruses, 2012-10, Vol.28 (10), p.1196-1206

2012

Volltextzugriff (PDF)

Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy

Journal of critical care, 2012-02, Vol.27 (1), p.51-57

2012

Volltextzugriff (PDF)

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America

Clinical infectious diseases, 2014-11, Vol.59 (9), p.e96-e138

2014

Volltextzugriff (PDF)

Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK

Journal of acquired immune deficiency syndromes (1999), 2013-05, Vol.63 (1), p.77-85

2013

Volltextzugriff (PDF)

Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection

AIDS (London), 2016-01, Vol.30 (3), p.405-414

2016

Volltextzugriff (PDF)

Oral sampling and human papillomavirus genotyping in HIV-infected patients

Journal of oral pathology & medicine, 2012-04, Vol.41 (4), p.288-291

2012

Volltextzugriff (PDF)

High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States

PLoS neglected tropical diseases, 2011-04, Vol.5 (4), p.e1034-e1034

2011

Volltextzugriff (PDF)

A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis

The Lancet infectious diseases, 2006-11, Vol.6 (11), p.742-748

2006

Volltextzugriff (PDF)

Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses

Journal of acquired immune deficiency syndromes (1999), 2010-09, Vol.55 (1), p.39-48

2010

Volltextzugriff (PDF)

Immune Activation Mediated Change in Alpha-1-Acid Glycoprotein: Impact on Total and Free Lopinavir Plasma Exposure

Journal of clinical pharmacology, 2011-11, Vol.51 (11), p.1539-1548

2011

Volltextzugriff (PDF)

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.339-354

2008

Volltextzugriff (PDF)

Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1—Infected Patients: 156-Week Results From STARTMRK

Clinical infectious diseases, 2011-10, Vol.53 (8), p.807-816

2011

Volltextzugriff (PDF)

T-cell receptor activator of nuclear factor-κB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts

AIDS (London), 2018-04, Vol.32 (7), p.885-894

2018

Volltextzugriff (PDF)

Disseminated Mycobacterium avium Complex Disease among Patients Infected with Human Immunodeficiency Virus, 1985–2000

Clinical infectious diseases, 2001-12, Vol.33 (11), p.1938-1943

2001

Volltextzugriff (PDF)

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.355-365

2008

Volltextzugriff (PDF)

Antiretroviral Therapy–Induced Bone Loss Is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-Naive Persons with Human Immunodeficiency Virus Infection: A Phase IIB Trial

Clinical infectious diseases, 2020-10, Vol.71 (7), p.1655-1663

2020

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(93)
Life Sciences & Biomedicine
(89)
Humans
(84)
Adult
(68)
Infectious Diseases
(65)
Female
(61)
Male
(61)
Hiv
(49)
Biological And Medical Sciences
(48)
Immunology
(48)
Middle Aged
(47)
Medical Sciences
(45)
Hiv Infections - Drug Therapy
(37)
Microbiology
(37)
Human Immunodeficiency Virus
(36)
Human Viral Diseases
(34)
Viral Diseases
(34)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(32)
Viral Load
(28)
Virology
(28)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

Methylprednisolone for Coronavirus Disease 2019 (COVID-19): Was Benjamin Rush Prescient?

Guidelines for the Management of Chronic Kidney Disease in HIV-Infected Patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

Impaired Hepatitis C Virus (HCV)-Specific Effector CD8+ T Cells Undergo Massive Apoptosis in the Peripheral Blood during Acute HCV Infection and in the Liver during the Chronic Phase of Infection

A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study

Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial

Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK

Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection

Oral sampling and human papillomavirus genotyping in HIV-infected patients

High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States

A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis

Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses

Immune Activation Mediated Change in Alpha-1-Acid Glycoprotein: Impact on Total and Free Lopinavir Plasma Exposure

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1—Infected Patients: 156-Week Results From STARTMRK

T-cell receptor activator of nuclear factor-κB ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts

Disseminated Mycobacterium avium Complex Disease among Patients Infected with Human Immunodeficiency Virus, 1985–2000

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

Antiretroviral Therapy–Induced Bone Loss Is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-Naive Persons with Human Immunodeficiency Virus Infection: A Phase IIB Trial

Suchergebnisse filtern